Cytokine-Based Tumor Immunotherapy

The use of immunostimulant monoclonal antibodies has revolutionized the treatment of cancer. To obtain the maximum potential from these treatments that stimulate the immune system, it is necessary to develop drugs based on molecules that mediate communication between the cells of the immune system: cytokines. The development of safe, effective drugs based on cytokines requires a thorough knowledge of the biology of these molecules and the design of sophisticated strategies to improve their therapeutic properties. This is the goal of the cytokine-based tumor immunotherapy group.

"The identification of new targets to potentiate immune responses to cancer is the first step toward safer and more effective antitumor drugs", Dr. Pedro Berraondo.

More information:


Cristina López
Avda. Pío XII, 55
31008 Pamplona

(+34) 948 194 700 Ext. 6021